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Two drugs known to inhibit the action of calmodulin, 
prochlorperazine (PCP) and N-(6-aminohexyl)-5-
chloro-l-napthalene sulfonamide (W7), were investi-
gated for their ability to control cell proliferation in 
murine B16 melanoma cells in culture. PCP and W7 
inhibited [3H]thymidine uptake in these cells, 50% in-
hibition occurring with 13 JLM PCP and 40 JLM W7. In the 
presence of relatively high concentrations of fetal calf 
serum (FCS), cells withstood high concentrations of both 
drugs (100 JLM PCP and 200 JLM W7) and showed in-
creased pigment production. Drug-inhibited DNA syn-
thesis could be reversed by the addition of fresh medium 
containing FCS or by the addition of exogenous pure 
calmodulin. Extracellular calmodulin itself stimulated 
DNA synthesis . FCS was found to contain calmodulin-
like activity at concentrations that may be relevant to 
the stimulation of r'H]thymidine uptake by cells in 
culture. 
There is ev idence t hat t he intracellular calcium receptor 
protein calmodulin plays an important role in cell division; 
ca lmodulin has been locali zed in the formation of t he mitotic 
spindle [1], and the leve l of calmodulin has been found to 
double at the GI /S transition phase of the cell cycle [2,3]. In 
addition, calmodulin antagonists have been reported to sup-
press cell division in some cell lines [4 ,5], and we have reported 
similar results in normal human lymphocytes [6]. The ca lmod-
ulin antagonists in use are not spec ific for the inhibit ion of 
calmodulin [7], but Boynton et al [4], in addressing this prob-
lem , fo und that triOuoperazine- inhibited cells could be stimu -
lated by t he add it ion of extracellular calmodulin and that 
extracellular calmodulin alone stimulated DNA synthesis. 
More recently, another report of stimulatory effects of extra-
cellular calmodulin on DNA synthesis in normal human lym-
phocytes has appeared [8]. 
In malignant cells, mitosis is reported to be less dependent 
on extracellular ca lcium than in nonneoplastic ce lls [9], and 
calmodulin content is reported to be elevated in several malig-
nant cell lines [10- 12]. 
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We have previously reported the purification of calmodulin 
from mouse B16 melanoma tumors [13], and in t he present 
study we investigate the use of two calmodulin antagonists, a 
phenot hiazine, prochlorperazine, and N-{6-aminohexyl)-5-
chloro- l -naphthalene sulfonamide (W7), reported to be more 
specific for the inhibition of calmodulin [5] in the control of 
ce ll proliferation in cells cultured from these tumors. In addi-
tion we examine the effect of ext.racellular calmodulin on DNA 
synthesis in t hese cells, and we compare the calmodulin content 
of t hese cells with that of other neoplastic and nonneoplastic 
cells. 
MATERIALS AND METHODS 
Moterials 
Cyclic ['IH]AMP and [' H] thymidine were obtained from Amersham 
In te rna t ional Limited, Bucks., U.K. Cyclic AMP, pure pig brain cal-
modulin, and calmodulin·deficient phosphodiesterase were obtained 
from Boehringer Mannheim, London. Snake venom (Oph':ophagus han -
nah) and Dowex 1-X8 (200- 400 mesh) anion exchange resin were 
obtained from Sigma Chemical Company, Poole, Dorset, U.K. 
Medium -] 99, phosphate-buffered saline (PBS), fetal calf serum 
(FCS) , glu tam ine, penicillin , and streptomycin were obtained from 
Gibco·Europe Limited, Pa isley, U.K. All t issue culture plastics were 
obta ined from Steri lin, Teddington, Middlesex, U.K. All other chemi -
cals were of analytical grade. 
Prochlorperazine (PCP) and prochlorperazine sulfoxide (PCPS) 
were gifts from Smith, Kline and French Labs., Limited, Welwyn 
Garden City, Herts., U.K. W7 was a gift from Dr. M. Blackburn, 
Sheffi eld University. 
Calmodulin Assay 
Heat. treated extracts of confluent cells were prepared as desc ribed 
previously [14]. Essentially, t issue culture medium was removed and 
ce lls rinsed with 0.9% (w/v) NaCI and buffer (40 mM Tns-HCI, pH 
7.4, at r?om temperature, 0.1 m~ Ca~12' 50 mg/ I phenylmet.hylsulfo; 
nylfluonde, and 50 1'1 / 1 pepstat1l1 A) 111 ~,he ra~lO of 1 ml pe: 9-cm 
culture dish added. Cells were detached from dIshes by scrap1l1g and 
homogenized using a glass Dounce homogenize r. A sample of homoge· 
nate was retained for protein measurement, (assay method as 111 [15]), 
and t he remainder was heated to 90· C for 5 min . Denatured protein 
was removed by centrifugation at 10,000Xg for 10 min, and superna· 
t.ants were stored at - 20· C un t il assay. 
Ca lmodulin activity in t hese ext.racts was measured by the ability of 
cell extracts to activate a calmodulin ·dependent cyclic nucleotide phos· 
phodiesterase, as used previously [6]. Optimal assay condi t ions, using 
a beef heart ca lmodulin phosphodiesterase obtained from Boehringer 
Mannheim, London, were as follows: Assays contained in a final 
reaction mixture of 400 1'1, 40 mM Tris-H CI, pH 7.0, at 37· C, 4 mM 2· 
mercaptoethanol, 5 mM MgCI" I"H] cyclic AMP (2 x 10" cpm/ tube), 
100 11M cycl ic AMP, 25 I'M CaCI2, and calmodulin or heat·t.reated cell 
extract as required. Incubations of 15 min at 37· C were commenced by 
the addition of enzyme (approx imately 1.5 mU/ tube) and terminated 
by t ransferring tubes to a boiling wate r bath . Tubes were then trans· 
ferred to ice. The 5' -AMP formed during this incubation with phos-
phodieste rase is t hen converted to adenosine by t.he 5' -nucleot.idase 
present in snake venom. Then 1001'1 snake venom in distilled water 
was added to the tubes and incubated for 10 min at 37· C before 
returning the tubes to ice. Product nucleosides were separated from 
unreacted substrate using Dowex anion exchange resin. Dowex slurry 
(1 ml; 1 part Dowex to 4 parts methanol) was added to each tube, and 
the contents were mixed and centrifuged at 1000g for ]0 min . Then 
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supernatant, contain ing adenosine, was decanted from each t ube a nd 
counted for tritiated adenosine us ing standa rd liquid scinti ll atio n 
counting techniques. Calmodulin activ ity in ce ll extracts a nd in heat-
treated extracts of FCS was determined at 3 dilutions for each extract, 
comparing the activ ity present with that produced by a pure calmodulin 
standard. This activity was then re lated to t he a mount of protein in 
the original ce ll homoge nate a nd the results expressed as mi lligrams of 
ca lmodu lin activ ity pe r milli gram of ce ll protein . 
f"H1Thymidine Uptahe into BI6 M elanoma. 
The B16 mouse melanoma was se ri a ll y t ra nsplanted in C57BL mice. 
Pr imary cu ltures we re der ived from t he t umors a nd grown in a CO2 
incubator in Medium-199 with Ha nks ' sa lts and 20 mM Hepes buffer 
supplemented with 10% FCS a nd contai ning penic illin (50 IU/m l) a nd 
streptomycin (50 I'g/ml). 
For l' Hjthymidine uptake, ce ll s were grown in multiwell plates (6 
we lls of 3.5 cm diameter) at a seeding dens ity of 1- 2 x 105 ce ll s per 
millilite r unti l ce ll s covered app roximately 25 % of the p lates (as dete r -
mined by eye; this usually took 2-3 days). Cell s were t he n washed with 
PBS a nd incubations commenced hy the addit ion of 1 ml of medium 
per well cont.a ining 1.5 I'C i [3Hlthymidine and calmodu lin or 
ca lmodu li n antagonists as required. Incubations were te rminated at 
t imes described by removal o f medium, and ce ll s were washed with 
PBS followed by 400 1'1 of 10% TCA for 10 min at 4°C a nd then fin a lly 
digested in 400 1'1 of 1 N NaOH fo r 16 h at 37°C. Radioactivity in t he 
ce ll diges ts was then measured . Incubations were performed in trip li -
cate, and each experiment was repeated on a minimum of 3 occas ions. 
Measurement of Pigmentation 
An indication of changes in t he amou nt of pigment presen t in 
melanoma cultures was obtai ned by ana lyzin g photographs o f confluen t 
cultures with an epidi ascope attached to a Quantamat 720 image-
ana lyzing computer (Camb ridge Instrumen ts Ltd.) in te rfaced wit h a 
Hewlett- Packard 9815A desktop calculator. For this study, ce ll s we re 
grown to confluence in 25-cm2 Falcon fl asks in Medium-199 with 
Hanks' salts a nd 20 mM H epes buffe r suppleme nted with 20% PCS 
a nd conta ining pe nici ll in (50 I U/ml) and strep tomycin (50 I'g/ml ). 
Other Cell Lines 
In add it ion to B 16 melanoma ce lls, primary cu ltu res of ce ll s were 
a lso obtained from human articu lar carti lage, huma n norma l bone, 
human nontox ic t hyroid goiter, huma n prolactinoma (using mate ri a l 
obtained from su rge ry), pig t hyro id (us ing freshly s la ugh te red animals), 
a nd osteogenic sarcoma tumo rs se rially t ra nsplanted in rats . A cloned 
ce ll line, rat G H, ce lls, derived from a rat pituitary tumor was a lso 
used. Cells were main ta ined in Ham's P Ia medium (GH,), Medium-
199 (pig a nd human thyro id), or DMEM (a ll othe rs). 
RESULTS 
The amount of biologically active calmodulin present in 
cultured BI6 melanoma cell s was compared with that present 
in other neoplastic and nonneop lastic cell s in t he labo ratory. 
All ce ll s were compared at confluence. As can be seen from 
Table I, calmodulin levels in B16 melanoma cells were similar 
to those found fo r several nonneoplastic cells at cont1uence. 
Two calmodulin antago nists were exam ined for their effects 
on ce ll division, a common phenothiaz ine, PCP, together with 
its relatively inactive calmodulin a ntago nist analogue, PCPS, 
TABLE 1. Calmodu,lin content in cultu red celL~ 
Cell 
Rat pitu itary GH3 ce ll s 
Mouse B16 melanoma cell sb 
Human articu lar cartilage chondrocytes 
Pig t hyro id ce llR (normal) 
Human thyro id ce lls (nontoxic go iter) 
Human normal bone ce ll s 
Rat os teogenic sarcoma cell s h 
Human prolactinoma ce Jl sb 
Calmodulin 
(I'g/mg protein, 
i ± SD, n = 3)" 
0.66 ± 0,03 
0.70 ± 0.04 
0.79 ± 0.07 
0 ,87 ± 0.03 
0.99 ± 0.11 
1.22 ± 0.11 
1.48 ± 0.21 
2.30 ± 0,05 
"Calmodu lin activity was determined in co nfluent cul t ures o f ce ll s 
as described in Materials and Methods. 
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F IG 1. Time course of inhibitory effect of W7 on ["Hj t hy midine 
upt.ake in B16 melanoma ce ll s . Left , [,IH1Thymidine uptake during 15 
min, 30 min, 1 h, 2 h , o r 4 h incubation with ["Hlthymidine (1.5 I'Ci / 
ml) in t he absence of drug (0) a nd in t he presence of 50 ,1M W7 (e), 
100 I'M W7 (_), or 200 I'M W7 (A), Resu lts s hown a re means ± SE of 
t riplicate cu ltures of a s ingle experiment, Right, The data shown on 
t he le ft is used to calculate t he degree o f inhibition of l3Hj t hymidine 
uptake produced by 50 I'M W7 (e), 100 I'M W7 (_) , and 200 I'M W 7 
(A) at each time point. 
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1"1(; 2. Effect of PCP (_), PCPS ("' ), and W7 (e) on ["H jthymidine 
uptake in B16 melanoma ce ll s over 48 h . Results a re means ± SE of 3 
experiments with PCP a nd PCPS a nd 4 experimen ts with W7. Control 
values for I"Hj t hym idine uptake, which ra n ged from 2 x 10" to 5 X 103 
cpm, are des ignated 100% to a llow experiments to be combined. 
and a drug reported to be more spec ific for calmodulin inhibi -
t ion, W7. 
The inhibition of DNA synthesis developed during the first 
2 h of exposure to the drugs as is shown in Fig 1 for the drug 
W7. During a more prolonged period of exposure to the drugs 
(48 h), this inhibition was main ta ined. Over this period (Fig 2), 
[3HJ thymidine uptake was reduced 50% by 40.5 ± 5.8 J.LM W7 
(x ± SE, 11 = 4) and 13.0 ± 3.9 pM PCP (x ± SE, 11 = 3). PCPS 
was without effect on ["HJthymidine uptake up to 100 J.LM. 
In addition to the inhibi tory effect of the drugs on DNA 
synthesis, it was clea r that under the experimental conditions 
desc ribed, higher concent rations of these drugs also caused cell 
detachment. This was apparent by eye and was also obvious in 
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the final protein content of the well s, which was less than that 
present at the beginning of incubations. This effect could be 
clearly separated in terms of concentrat ion dependence from 
the effect on DNA synthesis. In the experiments shown in Fig 
2 (us ing 10% FCS), a 50% reduction in the amount of cell 
protein remaining in t he wells at. the end of 48 h incubation 
occurred with 120 ± 24 pM W7 (x ± SE, n = 4) and 36.7 ± 7.2 
pM PCP (x ± SE, n = 3). PCPS had no effect on cell detac h-
ment. In the absence of FCS, cell detachment occurred rapidly, 
e.g., in one such experiment a 50% loss of attached cells 
occurred with 40 JlM W7 and 30 JlM PCP within 15 min. 
However, in the presence of 20% FCS, confluent cultures of 
melanoma cell s maintained in concentrations of W7 or PCP 
sufficient to complete ly inhibit cell division (200 pM W7 or 100 
pM PCP) showed minimal cell detachment and continued to 
produce pigment. This increase in pigmentation was evident 
by eye in conl1uent cu ltures of B16 mela noma after 4 to 5 days 
of exposure to these drugs and was verified by the use of an 
image-analyzing computer. Photographs of cultures exposed to 
200 JlM W7 for 5 days were an average of 145% darker than 
photographs of control cultures. Photographs of cultures ex-
posed to 100 JlM PCP for 5 days were 93 % darker than control 
cultures. 
Inhibition of DNA synthesis produced by the drugs cou ld be 
reversed either by replacement of medium or by addition of 
extracellula r pure calmodulin to the medium. Figure 3 shows 
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FIG 3. Effect of extracellular calmodulin a nd of medium replace-
ment on ["HJthymidine uptake in W7- inhibited cel ls. Resul ts shown 
a re means ± SE of t riplicate cultures of a single representative exper-
iment. Histograms 1- 8 represent results of I-ml cultures pretreated 
with either no drug (control, histogram 1) or 50 /lM (histograms 2- 8). 
All cultures were t hen incubated with l' Hlthymidine for 7 h, during 
wh ich period calmodulin was added to cultures represented by histo-
grams 3-5 (10, 100, and 1000 ng/ ml, respectively) and medium was 
cha nged in cultures 6- 8 for medium containing 5 10 or 20% FCS 
respectively. Asterisk indicates a significant increas~ (p'< 0.05) in [3Hj 
thymidine uptake compared with uptake in the presence of 50 /lM W7 
alone. 
TABLE II. Effect of extracellular calmodulin an ( 'H] thymidine uptake 
f'HJThymidine upt.ake (cpm x 10-3 per 48 h)" 
Experimentb + Calmodulin Control (1Ilg/ ml) Effect 
1 6.34 ± 0.32 9.44 ± 0.54 +49 % 
2 9.10 ± 0.9 15.0 ± 1.4 +65 % 
3 9.3 ± 0.6 20.9 ± 0.8 +125 % 
4 9.5 ± 1.5 16.6 ± 0.2 +75 % 
5 13.8 ± 1.6 14.5 ± 2.5 N.S. 
6 26.3 ± 3.5 27.5 ± 2.6 N.S. 
7 35.0 ± 1.3 36.0 ± 1.2 N.S. 
8 45.3 ± 4.3 47.1 ± 3.7 N.S. 
n ["H1Thymidine upta ke in cultures was as described in Materials 
and Methods. 
h Experiments are arranged in ascending order of ['H Jthymidine 
upta ke rather than in order of execution. 
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FIG 4. Stimulatory effect of extracellula r pure calmodulin on ["HI 
thymidine uptake over 48 h in 816 melanoma cultures containing 
either 10% (e) or 5% (0) FCS. Results shown a re means ± SE of 
triplicate cultures of a single experi ment. Values indicated by aste ris k 
represe nt ["HI thymidine upta ke in the absence of calmodulin . 
that ce lls exposed to 50 pM W7 for 18 h showed a significant 
increase in [:lHjthymidine uptake in response to the subsequent 
addition of 1 Jlg/ ml of pure calmodulin to t he medium . (Simi lar 
results have a lso been obtained using cells exposed to W7 for 2 
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or 4 h prior to calmodulin add ition.) This concentration of 
ca lmodulin rep resents 5.98 X 10- " mol calmodulin per 1 ml 
incubation, compared wi th t he 5 x lO-H mol W7 already present 
in the incubation. In t he experiment shown in Fig 3, [:'H] 
thym idine uptake was measured over 7 h of exposure to cal-
modu lin . The stimulatory response to calmodulin could be first 
detected between 1 and 2 h of exposure to ca lmodulin. DNA 
synthesis in W7-inhibi ted ce ll s could also be reversed by the 
replacement of medium conta ining FCS, as shown in Fig 3, 
with cells retain ing t he ability to respond to increasing concen-
trations of FCS. 
In an investigation of t he effects of extracellular ca lmodulin 
on DNA synthesis in t he absence of calmodulin antagonists, 
we fo und that t he respo nse of t he melanoma ce lls to extracel-
lular ca lmodulin varied and t hat this response appeared to be 
affected by t he concentration of FCS present. In 8 consecutive 
experiments in t he presence of 10% FCS, the addi t ion of pure 
ca lmodulin increased [:'HJthymidine uptake in 4 experimen ts, 
as shown in Table II. Calmodulin was effective in those exper-
iments havi ng t he lowest basal rate of ["HJthymidine incorpo-
ration. Since we knew that growth in B16 melanoma cells in 
culture is high ly dependent on t he concentration ofFCS present 
(maximally stimulating increase in [:'H]thymidine uptake pro-
duced by 25% FCS), we reduced FCS to 5% in several experi -
ments to see if t hi s wou ld facilitate t he study of the effects of 
extrace llula r calmodulin on [:'H]thymidine uptake in t hese 
cells. As shown in Fig 4, the stimulatory effects of extracellular 
calmodulin can be seen more clearly in t he presence of 5% 
rather than] 0% FCS. As li ttle as 100 ng/ml calmodulin (5.98 
x lO-g M) produced significant stimulation in t he presence of 
1'> % FCS. We subsequently examined FCS for t he presence of 
ca lmodulin -like activity and found calmodulin -like activity in 
6 different batc hes of FCS ranging from 0.9 to 8 Jig/ml (3.8 ± 
1.0 Jig/ml, i ± SE, n = 6) dete rmined by t he ability of heat-
t reated extracts of these sera to activate a ca lmodulin -depend-
ent phosphodiesterase. T his activity diluted in parallel to a 
pure ca lmodulin standard and was inhibited by t he addition of 
eit her EGTA (100 JiM) or W7 (100 JiM ). 
DISCUSS ION 
We found ca lmodulin content in B16 melanoma cells at 
confluence t.o be with in t he range found for nonneoplastic 
conlluent ce lls in ou r laboratory (0.66 to 1.22 Jig calmodulin 
pe r milligram of prote in) . However, increased calmodulin con-
tent has been reported in other neop lastic cell s [10- 12]. In the 
present study, neoplastic cell s derived from a rat osteosa rcoma 
and from a human prolactinoma showed calmodulin levels 64% 
and 155% greate r than the calmodulin levels (0.90 ± 0.08 I1 g 
ca lmodulin per milligram of protein, i ± SE) determined in 5 
nonneoplastic cell types. 
DNA synthes is in B16 melanoma cell s was inhibited by P CP 
and W7. The gradual development of inhibition over the first 
2 h of exposure to the drugs is probably exp lained by the use 
of nonsynchronized populations of ce lls in t hi s study, since 
Boynto n et al l4] found that only 15 min of preexposure to 
t rifluoperazine was sufficient to block the normal DNA-syn-
thetic response to ca lcium in rat liver cells. B16 melanoma cells 
grown in t he continued presence of t he drugs for 48 h did not 
escape from t his inhibit ion, although the inhibition was re-
versed by the remova l of drugs. In te rms of potency, we found 
that slight ly higher concent rations of W7 (40.5 ± 5.8 11M, i ± 
SE) and P CP (13.0 ± 3.9 JiM , i ± SE) are required for ha lf-
maximal inhibition of thymidine uptake in B16 melanoma cells 
t ha n a re required for the inhibition of calmodu lin -dependent 
phosphodiesterase activ ity [17]. These 50% inhibition values 
we re dete rmined in the presence of 10% FCS. Since subsequent 
experiments revea led FCS to conta in ca lmodulin -like activity, 
it is possible that t he calmodulin antago nists may appear more 
potent in t he abse nce of serum . 
With hoth P CP and W7 we obse rved cell detachment. Hidaka 
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et al [5], using 5% FCS, found t hat W7 detached cells from the 
plate at concentrations greater t han 60 JiM. We found that t he 
presence of higher concentrations of FCS (20%) appeared to 
give some measure of protection to the cells against t his effect 
of t he drugs on cell attachment. In addition, cells exposed to 
high concentrations of W7 and PCP in the presence of 20% 
FCS continued to produce pigment, having increased pigment 
production compared wit h control cultures. This suggests that 
the inhibitory action of the drugs on DNA synthesis is not 
simply due to a nonspecifically damaging effect of the drugs on 
the cell s and is further supported by t he finding that drug-
inhibited [:'H]thymidine uptake cou ld be restimulated by the 
subsequent addition of fresh medium containing FCS or, as in 
t he study of Boynton et al [4], by the subsequent addition of 
pure calmodulin. It should be emphasized that the pure cal-
modulin added was not present in sufficient concentration to 
itself inactivate the calmodulin antagonist drugs present in the 
cul ture medium. 
The effects of extrace llula r calmodulin on DNA synthesis 
were first described by Boynton et al [4] for rat liver cell s, and 
more recently, exogenous calmodulin has been reported to 
stimulate lymphocyte proliferation in humans [8] . T he stimu-
latory effects of extracellular calmodulin on thromboxane pro-
duction in human platelets have also been reported [18]. The 
mode of action of extracellular calmodulin is unknown. In our 
study we found significant stimulation could be observed at 6 
x 10- 9 M (100 ng/ml) if FCS were lowered to 5%. Medium 
containing F CS could also restimulate calmodulin antagonist-
inhibited cell divis ion. In t he studies of Boynton et a l [4] and 
Gorbacherskaya et al [8], higher concentrat ions of calmodulin 
were required for significant stimulation of cell growth (10- 7 M 
and 10- 6 M, respectively). Calmodulin , although presen t in a ll 
eukaryote tissues, has not so far been described in extracellular 
Iluid to the best of our knowledge. Our finding of calmodulin -
like activity in FCS is therefore surpri sing. Since we observed 
the stimulatory effects of pure calmodulin on cell proliferation 
at levels equivalent to the concentration of "calmodulin-like" 
activity in 10% FCS, our results suggest that the presence of 
this activity in FCS may merit further investigation. 
Our preliminary work (unpublished) suggests that the SOurce 
of calmodulin -like activ;ty in FCS is t he platelet. However, the 
growth promoting effects of FCS in t his study may be due to 
the presence of any of the many well -documented growth 
factors known to be present in FCS. 
In summary, t he purpose of the present study was to inves-
tigate whether calmodulin antagonists could be of use in inhib-
iting the growth of B16 melanoma cells in culture. We conclude 
that t hese drugs do inhibit n.:r]thymidine uptake in these cells, 
that t he effects of t hese drugs are persistent, and t hat t heir 
effects are not due to nonspecific damage to the cells. During 
the preparation of t hi s manuscript, two reports of the use of 
calmodulin antagonists in the treatment of growth in so lid 
tumors in animals have appeared [19 ,20]. The results of these 
studies, which include B16 melanoma tumors in mice [20], 
show that these drugs are effective in contro lling cell prolifer-
ation in neoplastic t issue in animals. 
We are parliculariy graleful lo Dr. Paul Wirdnam for his assistance 
in quantifying the color densities in the photographs of B16 melanoma 
cells and to Dr. M. Blackburn for the provision of W7. 
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